• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION AND THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • ADDICTION & DOPAMINE
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING BRAIN
      • FASTING CANCER
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUTAMATE & BRAIN
      • GLYCATION
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • MENAQUINONE 4
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME EXTRACT
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NON-OPIOID ANALGESICS (PLANT BASED)
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RECEPTOR “Κ OPIOID”
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    Adipogenesis
    July 6, 2020
    NOOTROPICS
    September 9, 2020
    1. A case control study on relationship between lung cancer and genetic polymorphism of CYP1A1, CYP2E1 and GSTM1 in Han Nationality in Guangzhou area
    2. A case control study on the impact of CYP2E1 and GST-M1 polymorphisms on the risk of lung cancer
    3. A Case–control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk …
    4. A case-control study of CYP2E1 (PstI) and CYP1A1 (MspI) polymorphisms in colorectal cancer
    5. A Case-Control Study on Effects of Genetic Polymorphisms of GSTM1, GSTT1, CYP1A1 and CYP2E1 on Risk of Lung Cancer.
    6. A comparison of substrate dynamics in human CYP2E1 and CYP2A6
    7. A comparison of the inhibitory effects of four volatile anaesthetics on the metabolism of chlorzoxazone, a substrate for CYP2E1, in rabbits
    8. A decrease in S-adenosyl-L-methionine potentiates arachidonic acid cytotoxicity in primary rat hepatocytes enriched in CYP2E1
    9. A dietary ethanol protocol for CYP2E1 induction in CD-1 mice and its application to studies on the genotoxicity, immunotoxicity and metabolism of low-level benzene.
    10. A Haplotype Analysis of CYP2E1 Polymorphisms in Relation to Alcoholic Phenotypes in Mexican Americans
    11. A High Throughput Screening Assay to Screen for CYP2E1 Metabolism and Inhibition Using a Fluorogenic Vivid® P450 Substrate
    12. A Meta-analysis of CYP2E1 Genetic Polymorphism and Gastric Cancer Susceptibility [J]
    13. A meta-analysis on association of CYP2E1 rs2031920 and rs3813867 polymorphisms with breast cancer risk
    14. A multiplex-PCR/RFLP procedure for simultaneous CYP2E1, mEH and GSTM1 genotyping
    15. A Nanosensor System Based On Disuccinimydyl–CYP2E1 for Amperometric Detection of the Anti-Tuberculosis Drug, Pyrazinamide
    16. A negative cooperativity mechanism of human CYP2E1 inferred from molecular dynamics simulations and free energy calculations
    17. A novel lipopolysaccharide‐modulated Jun binding repressor in intron 2 of CYP2E1
    18. A novel polymorphism rs1329149 of CYP2E1 and a known polymorphism rs671 of ALDH2 of alcohol metabolizing enzymes are associated with colorectal cancer in a …
    19. A novel role of CYP2E1 in human megakaryocyte development
    20. A polymorphism in the 5′-flanking region of the CYP2E1 gene and elevated lung adenocarcinoma risk in a Japanese population
    21. A reaction network model for CYP2E1-mediated metabolism of toxicant mixtures
    22. A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma
    23. A relationship between genetic polymorphisms of CYP2E1 and susceptibility of acute leukemia in Gansu population
    24. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma
    25. A single nucleotide polymorphism in the CYP2E1 gene promoter affects skatole content in backfat of boars of two commercial Duroc-sired crossbred populations
    26. A study for regulation of ethanol-inducible P450(CYP2E1) on CCl4-induced hepatic damage
    27. A study on the effects of Lauric acid on ROS formation and CYP2E1 mRNA expression in alcohol-induced HEPG2 cells
    28. A Study on the Optimization of CYP2E1 Enzyme Activity in C57Bl/6 Mouse Brain and Liver/C57Bl/6 Fare Beyin ve Karaciger Mikrozomlarinda CYP2E1 Enzim …
    29. A systematic evaluation of microRNAs in regulating human hepatic CYP2E1
    30. A systematically combined genotype and functional combination analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in different geographic areas of mainland …
    31. A temporal study on the histopathological, biochemical and molecular responses of CCl4-induced hepatotoxicity in CYP2E1-null mice
    32. A-71G> T Nucleotide Substitution uncouples IFN-[gamma]-dependent Suppression of CYP2E1 mRNA
    33. Abnormal liver function associated with polymorphism of GSTT1, GSTM1 and CYP2E1 in workers exposed to N, N-dimethylformamide
    34. Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect
    35. Acetaldehyde as a substrate for ethanol-inducible cytochrome P450 (CYP2E1)
    36. Acetaldehyde as well as ethanol is metabolized by human CYP2E1
    37. Acetaldehyde generating enzyme systems: roles of alcohol dehydrogenase, CYP2E1 and catalase, and speculations on the role of other enzymes and processes
    38. Acetaminophen alters microsomal ryanodine Ca2+ channel in HepG2 cells overexpressing CYP2E1
    39. Acetaminophen and Isoniazid treatment leads to oxidative stress and cytotoxicity in cerebellar granule neurons possibly by CYP2E1 activation
    40. Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes
    41. Acetone catabolism by cytochrome P450 2E1: studies with CYP2E1-null mice
    42. Aconitine, a famous active and toxic alkaloid, has no impact on the activities of CYP1A2, CYP2D6, CYP2E1, and CYP3A in rats
    43. Action-mechanisms of Genetic Polymorphism in the CYP2E1 on Susceptibility to Polycyclic Aromatic Hydrocarbons
    44. Activation of alkylhydrazines to free radical intermediates by ethanol-inducible cytochrome P-4502E1 (CYP2E1)
    45. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics
    46. Activity of immobilised rat hepatic microsomal CYP2E1 using alumina membrane as a support
    47. Acute ethanol pretreatment increases FAS-mediated liver injury in mice: role of oxidative stress and CYP2E1-dependent and-independent pathways
    48. Additive effects of mitochondrion-targeted cytochrome CYP2E1 and alcohol toxicity on cytochrome c oxidase function and stability of respirosome complexes
    49. Adenovirus mediated overexpression of CYP2E1 increases sensitivity of HepG2 cells to acetaminophen induced cytotoxicity
    50. Adenovirus‐mediated expression of Cu/Zn‐or Mn‐superoxide dismutase protects against CYP2E1‐dependent toxicity
    51. Adenovirus-mediated expression of CYP2E1 produces liver toxicity in mice
    52. ADH2 and CYP2E1 genetic polymorphisms: risk factors for alcohol-related birth defects
    53. Administration of the tris salt of α-tocopheryl hemisuccinate inactivates CYP2E1, enhances microsomal α-tocopherol levels and protects against carbon tetrachloride …
    54. Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective
    55. Adverse Birth Outcomes Associated with Maternal Smoking and Polymorphisms in the N-Nitrosamine-Metabolizing Enzyme Genes NQO1 and CYP2E1
    56. Age-dependent features of CYP3A, CYP2C, and CYP2E1 functioning at metabolic syndrome
    57. Ageing is associated with increased expression but decreased activity of CYP2E1 in male Wistar rats
    58. Age-related changes in the protein and mRNA levels of CYP2E1 and CYP3A isoforms as well as in their hepatic activities in Wistar rats. What role for oxidative stress?
    59. ALCOHOL AND CANCER SY05-1 CARCINOGENIC ETHENO DNA ADDUCTS GENERATED DURING INFLAMMATION AND CYP2E1 INDUCTION IN VARIOUS …
    60. Alcohol intake and folate antagonism via CYP2E1 and ALDH1: Effects on oral carcinogenesis
    61. Alcohol Suppresses Cardiovascular Diurnal Variations In Male Normotensive Rats: Role Of Reduced PER2 Expression And CYP2E1 Hyperactivity In The Heart
    62. Alcoholic liver disease: from CYP2E1 to CYP2A5
    63. Alcohol-Induced Increase in the Content of CYP2E1 in Human Liver Microsomes Causes a Multifold Activation of CYP3A4 and Attenuates its Cooperativity
    64. ALDH2 and CYP2E1 genotypes, urinary acetaldehyde excretion and the health consequences in moderate alcohol consumers
    65. All trans retinoic acid modulates TNF-α and CYP2E1 pathways and enhances regression of ethanol-induced fibrosis markers in hepatocytes and HSCs in abstaining …
    66. Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian …
    67. ALLELIC VARIANTS OF CYP2E1 GENE IN HEPATOCARCINOMA PATIENTS AND IN HEPATIC TUMOR CELL LINES
    68. Allylnitrile metabolism by CYP2E1 and other CYPs leads to distinct lethal and vestibulotoxic effects in the mouse
    69. Alteration in the expression of cytochrome P450s (CYP1A1, CYP2E1, and CYP3A11) in the liver of mouse induced by microcystin-LR
    70. Alterations in toxicokinetics of trichloroethylene (TCE) and trichloroacetic acid (TCA) due to cytochrome P450 2E1 (CYP2E1) induction
    71. Altered ethylbenzene-mediated hepatic CYP2E1 expression in growth hormone-deficient dwarf rats
    72. Amelioration of oxidative stress by dandelion extract through CYP2E1 suppression against acute liver injury induced by carbon tetrachloride in sprague‐dawley rats
    73. An estimate of polymorphism of ADH1B, ALDH2, and CYP2E1 alcohol biotransformation genes in Siberian indigenous and immigrant populations
    74. An improved in vitro method for screening toxin and medicine targeting CYP2E1
    75. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A)
    76. An investigation of CYP2E1 phenotype determination utilizing modeling and simulation studies
    77. An investigation of the induction of hepatic CYP2E1 by low doses of nicotine in the rat.
    78. An Rsa I Polymorphism in the CYP2E1 Gene Does Not Affect Lung Cancer Risk in a Japanese Population
    79. An Updated Meta-Analysis On CYP2E1 RsaI/PstI And DraI Polymorphisms And Risk Of Anti-Tuberculosis Induced Hepatotoxicity: Evidence From 26 Studies
    80. Analysis of CYP2E1 and GSTM1 polymorphisms for the determination of genetic susceptibility to Korean patients with colon cancer
    81. Analysis of CYP2E1 polymorphism for the determination of genetic susceptibility to gastric cancer in Koreans
    82. Analysis of CYP2E1, GSTM1 genetic polymorphisms in relation to human lung cancer and esophageal carcinoma
    83. Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling
    84. Analysis of ethanol metabolic enzymes in primary human mammary epithelial cells and MCF‐10A cells: possible participation of CYP2E1 in ethanol‐induced oxidative …
    85. Analysis of human CYP2E1 mRNA in a HepG2 cell line by reverse transcription-polymerase chain reaction (RT-PCR)
    86. Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population.
    87. Analysis of protein and mRNA expressions of CYP1A1, CYP2E1, NQO1 and GST enzymes in liver, colon and prostate cancer cell lines to study drug and …
    88. and CYP2E1 and N‐terminal truncated CYP1A1 proteins in Saccharomyces cerevisiae − role of protein kinase A in the mitochondrial targeting of CYP2E1
    89. Antibiotic furazolidone induces CYP1A but not CYP2E1 subfamily in rat liver
    90. Antioxidant and pro-oxidant effects of a manganese porphyrin complex against CYP2E1-dependent toxicity
    91. Antioxidant and pro-oxidant mechanisms of (+) catechin in microsomal CYP2E1-dependent oxidative stress
    92. Antioxidant Peptides from Protein Hydrolysate of Microalgae Navicula incerta and their Protective Effects in Hepg2/CYP2E1 Cells Induced by Ethanol
    93. Antioxidant Properties of Proanthocyanidins Attenuate Carbon Tetrachloride (CCl4)–Induced Steatosis and Liver Injury in Rats via CYP2E1 Regulation
    94. Apigenin protects against alcohol-induced liver injury in mice by regulating hepatic CYP2E1-mediated oxidative stress and PPARα-mediated lipogenic gene …
    95. APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson’s disease in a Japanese population
    96. Application of a map Bayesian method for CYP2E1 phenotyping
    97. Application of an updated physiologically based pharmacokinetic model for chloroform to evaluate CYP2E1-mediated renal toxicity in rats and mice
    98. Area Under the Plasma Concentration–Time Curve of Inorganic Fluoride Following Sevoflurane Anesthesia Correlates with CYP2E1 mRNA Level in …
    99. Aspartame administration and insulin treatment altered brain levels of CYP2E1 and CYP3A2 in streptozotocin-induced diabetic rats
    100. Assessing Specificity of Indazole Derivatives as Inhibitors to CYP2E1
    101. Assessment of frequencies of lifestyle factors and polymorphisms of drug-metabolizing enzymes (NAT2, CYP2E1) in human hepatocellular carcinoma (HCC) patients …
    102. Association analysis of alcohol metabolizing enzymes ADH1B, ADH7, CYP2E1 gene polymorphism with risk for coronary atherosclerosis
    103. Association analysis of SNPs in the porcine CYP2E1 gene with skatole, indole, and androstenone levels in backfat of a crossbred pig population
    104. Association between CYP2E1 and GOT2 gene polymorphisms and susceptibility and low-dose N,N-dimethylformamide occupational exposure-induced liver injury
    105. Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis
    106. Association between CYP2E1 genetic polymorphisms and urinary cancer risk: a meta-analysis
    107. Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma
    108. Association between CYP2E1 polymorphisms and risk of gastric cancer: An updated meta‑analysis of 32 case‑control studies
    109. Association between CYP2E1 polymorphisms and susceptibility to prostate cancer
    110. Association between genetic polymorphism of GSTM1, CYP2E1 and susceptibility to cervical cancer and its precancerous lesions in Uighur women in Xinjiang
    111. Association between genetic polymorphisms of CYP2E1 and lung cancer susceptibility: a case control study
    112. Association between genetic variants in CYP2E1 and CTRC genes and susceptibility to alcoholic pancreatitis: A systematic review and meta-analysis
    113. Association between polymorphism of GSTP1, GSTT1, GSTM1 and CYP2E1 genes and susceptibility to benzene-induced hematotoxicity
    114. Association between polymorphisms in the CYP1A1, CYP2E1 and GSTM1 genes, and smoking, alcohol and upper digestive tract carcinomas in a high …
    115. Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis
    116. Association between the TP53 and CYP2E1* 5B gene polymorphisms and non-small cell lung cancer
    117. CYP2E1_gene_polymorphism.13.aspx”>Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai’an population, China
    118. CYP2E1_gene_polymorphisms_with_prostate_cancer_in_a_Lebanese_population/links/5635d13b08aebc003fff7840.pdf”>Association of CYP1A1 and CYP2E1 gene polymorphisms with prostate cancer in a Lebanese population
    119. Association of CYP2E1 and CYP1A1m2 (BsrD1) polymorphisms with cytogenetic biomarkers in petrol pump workers
    120. Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease
    121. Association of CYP2E1 gene polymorphism with predisposition to cancer development
    122. Association of CYP2E1 gene polymorphisms with bladder cancer risk: A systematic review and meta-analysis
    123. Association of CYP2E1 of PON2311 polymorphisms in neonates with preterm
    124. Association of CYP2E1, GST and mEH genetic polymorphisms with urinary acrylamide metabolites in workers exposed to acrylamide
    125. Association of CYP2E1, NQO1 and GST genetic polymorphisms with risk of acute lymphoblastic leukemia in turkish children
    126. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning.
    127. Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta …
    128. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: A case‐control study in Chinese population
    129. Association of GSTM1, GSTT1 and CYP2E1 gene polymorphisms with antituberculosis drug induced hepatotoxicity in North Indian population
    130. Association of GSTM1, GSTT1, GSTP1 and CYP2E1 single nucleotide polymorphisms with colorectal cancer in Iran
    131. Association of GSTM1, P1, T1 and CYP2E1 Single Nucleotide Polymorphisms with Colorectal Cancer in Iran: 391
    132. Association of mitochondrial deoxyribonucleic acid mutation with polymorphism in CYP2E1 gene in oral carcinogenesis
    133. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity
    134. Association of radiation risk in the second and third generations with polymorphisms in the genes CYP1A1, CYP2E1, GSTP1 and changes in the thyroid
    135. Association of the blood biochemical index with CYP2E1 5’flanking region Rsa I/Pst I gene polymorphism and alcohol consumption habit in Southern Taiwan …
    136. Association of the CYP2E1, FMO3, NQO1, GST, NOS3 genetic polymorphisms with ischemic stroke risk in Turkish population
    137. Association Studies of Polymorphisms of CYP2E1 Gene in Alcoholics with Cirrhosis, Antisocial Personality, and Normal Controls
    138. Associations between CYP1A1 and CYP2E1 polymorphisms and susceptibility to esophageal cancer in Chaoshan and Taihang areas of China
    139. Associations between CYP2E1 promoter polymorphisms and plasma 1, 3-dimethyluric acid/theophylline ratio
    140. Associations between CYP2E1 promoter polymorphisms and plasma 1, 3-dimethyluric acid/theophylline ratios
    141. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens
    142. Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis
    143. Associations of Rsa I polymorphism at the 5’flanking region of CYP2E1 and PON2 148 polymorphism in neonates with preterm delivery
    144. Author Correction: Effect of BI-1 on insulin resistance through regulation of CYP2E1
    145. Author’s Reply to Reith:“Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen”
    146. Autophagy protects against CYP2E1/chronic ethanol-induced hepatotoxicity
    147. B107 TUBERCULOSIS: ISSUES DURING TREATMENT: An Updated Meta-Analysis On CYP2E1 Rsai/psti And Drai Polymorphisms And Risk Of Anti-Tuberculosis …
    148. Baicalin ameliorates liver injury induced by chronic plus binge ethanol feeding by modulating oxidative stress and inflammation via CYP2E1 and NRF2 in …
    149. Benzene-induced genotoxicity in mice in vivo detected by the alkaline comet assay: reduction by CYP2E1 inhibition
    150. bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in …
    151. Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation
    152. Binge alcohol promotes acute liver injury through a CYP2E1‐HIF‐1α‐dependent apoptosis pathway in mice and humans (1010.1)
    153. Binge alcohol promotes hypoxic liver injury through a CYP2E1–HIF-1α-dependent apoptosis pathway in mice and humans
    154. Bioactivation of 1, 1-dichloroethylene by CYP2E1 and CYP2F2 in murine lung
    155. Bioactivation of 1, 1-dichloroethylene to its epoxide by CYP2E1 and CYP2F enzymes
    156. Bioinformatic Analysis of the Main Characteristics and Structure of the Gene Encoding CYP2E1 Protein.
    157. Bioinformatics of CYP2E1 CpG intron methylation sites and application to HAR1-RELN sequence analysis
    158. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.
    159. Bortezomib alleviates drug-induced liver injury by regulating CYP2E1 gene transcription
    160. Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics
    161. Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry
    162. Butadiene-induced mitochondrial dysfunction is correlated with mitochondrial CYP2E1 activity in Collaborative Cross mice
    163. by allyl sulfides and phenethyl isothiocyanate of methyl-n-pentylnitrosamine depentylation by rat esophageal microsomes, human and rat CYP2E1, and Rat CYP2A3
    164. Ca2+-dependent and independent mitochondrial damage in HepG2 cells that overexpress CYP2E1
    165. Camelus dromedarius Putative Cytochrome P450 Enzyme CYP2E1: Complete Coding Sequence and Phylogenetic Tree
    166. Caralluma umbellata Haw. protects liver against paracetamol toxicity and inhibits CYP2E1
    167. CARBON MONOXIDE PROTECTS MICROSOMES FROM ETHANOL-DERIVED OXIDATIVE STRESS MEDIATED BY CYP2E1
    168. Case Control Study of Genetic Polymorphism of Cytochrome P4502E1 5′(CYP2E1 5′) and Susceptibility of Occupational Manganism [J]
    169. Case-control study of the polymorphisms of CYP2E1-RsaⅠ and GSTT1 genes and susceptibility to pancreatic cancer
    170. CCl 4-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat
    171. cDNA sequence, deduced amino acid sequence, predicted gene structure and chemical regulation of mouse CYP2E1
    172. Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology
    173. Changes in coumarin kinetics and subcellular localization of CYP2E1 contribute to bile duct damage and reduce hepatocellular damage after repeated administration …
    174. Changes of CYP2E1 activity in diabetic rat model
    175. Characterization of a dietary ethanol protocol for CYP2E1 induction in the CD-1 mouse without evident hepatic toxicity or genotoxicity
    176. Characterization of cytochrome P4502E1 turnover in transfected HepG2 cells expressing human CYP2E1
    177. Characterization of polymorphisms of genes ADH2, ADH3, ALDH2 and CYP2E1 and relationship to the alcoholism in a Colombian population
    178. Chemical characteristics for optimizing CYP2E1 inhibition
    179. CHIP−/−-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications
    180. Chlormethiazole, an inhibitor of CYP2E1, prevented chemical carcinogen-initiated and alcohol-promoted hepatic carcinongenesis in rats.
    181. CYP2E1_Activity_in_Humans/links/54b536b40cf26833efd080d9.pdf”>Chlorzoxazone as a Single Sample Probe of Hepatic CYP2E1 Activity
    182. Chlorzoxazone as a single sample probe of hepatic CYP2E1 activity in humans
    183. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1
    184. Chlorzoxazone metabolism by winter flounder liver microsomes: evidence for existence of a CYP2E1-like isoform in teleosts
    185. Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans
    186. Chlorzoxazone: An in vitro and in vivo substrate probe for liver CYP2E1
    187. Chronic administration of caderofloxacin, a new fluoroquinolone, increases hepatic CYP2E1 expression and activity in rats
    188. Chronic alcohol intake-induced oxidative stress and apoptosis: role of CYP2E1 and calpain-1 in alcoholic cardiomyopathy
    189. Chronic ethanol and high glucose inducible CYP2E1 mediated oxidative stress leads to greater cellular injury in VL-17A cells: a potential mechanism for liver injury …
    190. Chronic ethanol feeding potentiates Fas Jo2-induced hepatotoxicity: Role of CYP2E1 and TNF-α and activation of JNK and P38 MAP kinase
    191. Cloning and bioinformatics revealed molecular characterisation of CYP2E1 gene from bactrian camel (Camelus bactrianus)
    192. Cloning and expression of rat CYP2E1 in Saccharomyces cerevisiae: Detection of genotoxicity of N‐alkylformamides
    193. Cloning and sequence analysis of human embryonic nasopharyngeal epithelial CYP2E1 cDNA
    194. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma
    195. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity
    196. Comment on:“Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen”
    197. Comparative analysis of binding affinities between styrene and mammalian CYP2E1 by bioinformatics approaches
    198. Comparative metabolism and disposition of trichloroethylene in CYP2E1–/–and wild-type mice
    199. Comparing the protective effects of three sulfur compounds against acrylonitrile-induced acute toxicity in CYP2E1-induced rats
    200. Comparison of chlorzoxazone one-sample methods to estimate CYP2E1 activity in humans
    201. Comparison of cytochrome P4502E1 (CYP2E1) activity and hepatic and lymphocyte mRNA expression in patients with chronic hepatitis C
    202. Comparison of genetic polymorphisms of CYP2E1, ADH2, and ALDH2 genes involved in alcohol metabolism in Koreans and four other ethnic groups
    203. Comparison of germ cell mutagenicity in male CYP2E1-null and wild-type mice treated with acrylamide: evidence supporting a glycidamide-mediated effect
    204. Comparison of levels of cytochromes P‐450, CYP1A2, CYP2E1, and their related monooxygenase activities in human surgical liver samples
    205. COMPARISON OF POLYMORPHISM rs2070672 CYP2E1 GENE PROPORTION IN EARLY AND ADVANCED STAGE OF UNDIFFERENTIATED TYPE …
    206. CYP2E1-gene-in-various-clinical-stage-of-undifferentiated-type-nasopharyngeal-carcinoma/”>Comparison of Polymorphism rs3813865 Cytochrome P450 Family 2 Subfamily E Polypeptide 1 (CYP2E1) Gene in Various Clinical Stage of Undifferentiated …
    207. Comparison of the polymorphic regions of the cytochrome P450 CYP2E1 gene of humans and patas and cynomolgus monkeys
    208. Comparison of the susceptibility of wild-type and CYP2E1 knockout mice to the hepatotoxic and pneumotoxic effects of styrene and styrene oxide
    209. Compatible effects of euphorbia and glycyrrhiza on CYP2E1 expression and activity in rat liver
    210. Computational Docking Investigations of Oxidative Metabolism of 4-Nitroanisole with CYP2E1
    211. Computational Docking Simulations of Nitroanisole and Nitrophenol with CYP2E1
    212. Computational docking studies of nitroanisoles and nitrophenols with CYP2E1
    213. Concentration-dependent inhibitory effect of Baicalin on the plasma protein binding and metabolism of chlorzoxazone, a CYP2E1 probe substrate, in rats in …
    214. Conformational anti‐cytochrome P4502E1 (CYP2E1) auto‐antibodies contribute to necro‐inflammatory injury in chronic hepatitis C
    215. Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice
    216. Construction and assessment of models of CYP2E1: predictions of metabolism from docking, molecular dynamics, and density functional theoretical calculations
    217. Construction and Identification of miRNA Expression Vector Targeting on Mouse CYP2E1
    218. Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order
    219. Construction of CRISPR/Cas9-mediated genomic deletion of the CYP2E1 gene in human HEK293FT cell line
    220. Construction of CYP2E1 recombinant adenovirus vector and its anti-tumor effects
    221. Contributing Roles of CYP2E1 and Other Cytochrome P450 Isoforms in Alcohol-Related Tissue Injury and Carcinogenesis
    222. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
    223. Contribution of CYP2E1 polymorphism to aging in the mechanical workshop workers
    224. Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism
    225. Contribution of the ALDH2 and CYP2E1 genes to flushing response and drinking patterns in Japanese healthy volunteers
    226. Contributions of caspase-8 and-9 to liver injury from CYP2E1-produced metabolites of halogenated hydrocarbons
    227. CONTROL OF BOAR TAINT BY USING GENETIC MARKERS: A SINGLE NUCLEOTIDE POLYMORPHISM IN THE CYP2E1 GENE PROMOTER AFFECTS …
    228. Cooperativity in CYP2E1 metabolism of acetaminophen and styrene mixtures
    229. Correction to The Action of Cytochrome b5 on CYP2E1 and CYP2C19 Activities Requires Anionic Residues D58 and D65
    230. Correction to: CYP2E1-mediated oxidative stress regulates HO-1 and GST expression in maneb-and paraquat-treated rat polymorphonuclear leukocytes
    231. Correlation analyses of ALDH2 and CYP2E1 genetic polymorphism with personality
    232. Correlation between genetic polymorphism in CYP2E1, GST and toxicity of dimethylformamide
    233. CORRELATION BETWEEN GENETIC POLYMORPHISM OF CYP2E1 AND SUSCEPTIBILITY OF ESOPHAGEAL CANCER IN GANSU PROVINCE
    234. Correlation between genetic polymorphisms of CYP2E1 DraⅠ and susceptibility of gastric cancer in Qinghai province
    235. Correlation between genetic polymorphisms of CYP2E1 DraⅠ and susceptibility of gastric cancer in Qinghai province [J]
    236. CORRELATION BETWEEN GENETIC POLYMORPHISMS OF CYP2E1 RSAⅠ AND SUSCEPTIBILITY OF GASTRIC CANCER IN QINGHAI PROVINCE [J]
    237. Correlation between spermatogenesis disorders and rat testes CYP2E1 mRNA contents under experimental alcoholism or type I diabetes
    238. Covalent immobilization of recombinant human cytochrome CYP2E1 and glucose-6-phosphate dehydrogenase in alumina membrane for drug screening applications
    239. Covalent modification and time-dependent inhibition of human CYP2E1 by the meta-isomer of acetaminophen
    240. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis
    241. Crosstalk between CYP2E1 and CYP3A enzymes and its Possible Involvement in Alcohol‐Drug Interactions.
    242. Cryopreserved porcine hepatocytes: expression and induction of cytochrome P450, isoform CYP2E1
    243. Cutaneous CYP2E1 induction after topical treatment by dexamethasone, ethanol and salicylic acid in mouse.
    244. Cyclosporine A protects against arachidonic acid toxicity in rat hepatocytes: role of CYP2E1 and mitochondria
    245. CYP17A1 and CYP2E1 variants associated with high altitude polycythemia in Tibetans at the Qinghai-Tibetan Plateau
    246. CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir
    247. CYP1A1 and CYP2E1 polymorphism frequencies in a large Brazilian population
    248. CYP1A1 CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous‐cell carcinoma of the esophagus
    249. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell …
    250. CYP1A1, CYP2E1 and EPHX1 polymorphisms in sporadic colorectal neoplasms
    251. CYP1A1, CYP2E1 and gastric cancer risk in a high-incidence Colombian population
    252. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people
    253. CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese
    254. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head …
    255. CYP1A1, CYP2E1, GSTM1, GSTT1, GSTP1, and TP53 polymorphisms: do they indicate susceptibility to chronic obstructive pulmonary disease and non-small-cell …
    256. CYP1A2* 1C, CYP2E1* 5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients
    257. CYP1AI and CYP2E1 gene polymorphisms may increase susceptibility to Oral Submucous Fibrosis among betel quid chewers of Eastern India
    258. CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro
    259. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism
    260. CYP2E1
    261. CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling
    262. CYP2E1 activity and children with obesity: possible confounding factors
    263. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease
    264. CYP2E1 activity in cisplatin resistant cancer cells
    265. CYP2E1 activity in patients with alcoholic liver disease
    266. CYP2E1 activity on ARPE-19 cells: New approach to RPE ethanol metabolism
    267. CYP2E1 and ALDH2 Gene Polymorphisms in Squamous Cell Head and Neck
    268. CYP2E1 and ALDH2 gene polymorphisms in squamous cell head and neck cancer in the Turkish population
    269. CYP2E1 and ALDH2 genotypes and alcohol dependence in Japanese
    270. CYP2E1_and_catalase_influence_ethanol_sensitivity.7.aspx”>CYP2E1 and catalase influence ethanol sensitivity in the central nervous system
    271. CYP2E1 and clinical features in alcoholics
    272. CYP2E1 and CYP3A1/2 gene expression is not associated with the ursodeoxycholate effect on ethanol-induced lipoperoxidation
    273. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
    274. CYP2E1 and GSTM1 gene polymorphisms, environmental factors, and the susceptibility to lung cancer
    275. CYP2E1 and miRNA‐378a‐3p contribute to acetaminophen‐or tripterygium glycosides‐induced hepatotoxicity
    276. CYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese population
    277. CYP2E1_and_nqo1_genotypes,_smoking_and_bladder.6.aspx”>CYP2E1 and NQO1 genotypes, smoking and bladder cancer
    278. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease
    279. CYP2E1 and oxidative liver injury by alcohol
    280. CYP2E1 and Parkinson’s disease in a MPTP-induced C57BL/6 mouse model
    281. CYP2E1 and risk of chemically mediated cancers
    282. CYP2E1_and_XRCC1_Genetic_Polymorphisms_and_the.906.aspx”>CYP2E1 and XRCC1 Genetic Polymorphisms and the Risk of Liver Fibrosis in Workers Exposed to Vinyl Chloride Monomer
    283. CYP2E1 autoantibodies in liver diseases
    284. CYP2E1 changes the biological function of gastric cancer cells via the PI3K/Akt/mTOR signaling pathway
    285. CYP2E1 competes with CYP2B4 for limited NADPH‐Cytochrome P450 Reductase
    286. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90
    287. CYP2E1 enhances ethanol-induced lipid accumulation but impairs autophaghy in HepG2 E47 cells
    288. CYP2E1 epigenetic regulation in chronic, low-level toluene exposure: Relationship with oxidative stress and smoking habit
    289. CYP2E1 expression in bone marrow and its intra-and interspecies variability: approaches for a more reliable extrapolation from one species to another in the risk …
    290. CYP2E1 expression in human lymphocytes from various ethnic populations
    291. CYP2E1 Expression in Liver of Type 2 Diabetic Rats [J]
    292. CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck
    293. CYP2E1 gene polymorphism and ovarian cancer risk in the Yakut population
    294. CYP2E1 GENE POLYMORPHISM AND SUSCEPTIBILITY OF HEPATOCELLULAR CARCINOMA IN QINGHAI TIBETAN POPULATION
    295. CYP2E1 gene polymorphisms related to the formation of coronary artery lesions in Kawasaki disease
    296. CYP2E1 Gene Promoter Polymorphism -1293G>C Increases the Risk of Essential Hypertension in Men with Alcohol Abuse
    297. CYP2E1 gene rs6413420 polymorphism was first found in the Bouyei ethnic group of China
    298. CYP2E1 Genetic Polymorphism relating to Styrene Metabolism of Korean Workers
    299. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan
    300. CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis
    301. CYP2E1 genotype and transaminase level of tuberculosis patients receiving fixed dose combination of antituberculosis
    302. CYP2E1 genotypes and serum LAP in Japanese alcoholics
    303. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.
    304. CYP2E1 hydroxylation of aniline involves negative cooperativity
    305. CYP2E1 immunoglobulin G4 subclass antibodies after desflurane anesthesia
    306. CYP2E1 impairs GLUT4 gene expression and function: NRF2 as a possible mediator
    307. CYP2E1 in the human retinal pigment epithelium: expression, activity, and induction by ethanol
    308. CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation
    309. CYP2E1 induction leads to oxidative stress and cytotoxicity in glutathione-depleted cerebellar granule neurons
    310. CYP2E1 inhibition enhances mallory body formation
    311. CYP2E1 is a central mediator for the synergistic effects of alcohol and free fatty acids on hepatocellular steatosis and inflammation
    312. CYP2E1 is not involved in early alcohol-induced liver injury
    313. CYP2E1 is preferentially expressed in Clara cells of murine lung: localization by in situ hybridization and immunohistochemical methods.
    314. CYP2E1 level in peripheral lymphocytes correlates with early pathogenesis of diabetic nephropathy.
    315. CYP2E1 level in rat liver injured by the interaction between carbon tetrachloride and chloroform
    316. CYP2E1 mediated ethanol metabolism in ARPE-19 cells.
    317. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats
    318. CYP2E1 Mediates Ethanol-Induced DNA Damage And TNF Release In Bronchial Epithelial Cells
    319. CYP2E1 metabolism of styrene involves allostery
    320. CYP2E1 mRNA expression, genetic polymorphisms in peripheral blood lymphocytes and liver abnormalities in Chinese VCM-exposed workers
    321. CYP2E1 mutation associated with increased chlorzoxazone (CZ) metabolic ability
    322. CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling
    323. CYP2E1 overexpression in HepG2 cells induces glutathione synthesis by transcriptional activation of γ-glutamylcysteine synthetase
    324. CYP2E1 overexpression inhibits microsomal Ca2+-ATPase activity in HepG2 cells
    325. CYP2E1 overexpression up-regulates both non-specific ô-aminolevulinate synthase and heme oxygenase-1 in the human hepatoma cell line HLE/2E1
    326. CYP2E1 overexpression up-regulates both non-specific δ-aminolevulinate synthase and heme oxygenase-1 in the human hepatoma cell line HLE/2E1
    327. CYP2E1 phenotype in Mexican workers occupationally exposed to low levels of toluene
    328. CYP2E1 polymorphism, acetylator profiles and drug-induced liver injury incidence of Indonesian tuberculosis patients
    329. CYP2E1 polymorphism, cigarette smoking, p53 expression, and survival in non-small cell lung cancer: a long term follow-up study
    330. CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and meta-analysis
    331. CYP2E1 polymorphisms and gene–environment interactions in the risk of upper aerodigestive tract cancers among Indians
    332. CYP2E1 polymorphisms and nasopharyngeal carcinoma risk: a meta-analysis
    333. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis
    334. CYP2E1 potentiates toxicity in obesity and after chronic ethanol treatment
    335. CYP2E1 potentiation of LPS and TNFα-induced hepatotoxicity by mechanisms involving enhanced oxidative and nitrosative stress, activation of MAP kinases …
    336. CYP2E1 PstI polymorphism increases cervical neoplasia risk: a meta-analysis
    337. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis
    338. CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls
    339. CYP2E1 recovery is associated with a pericentral fibrosis pattern after repeated CCl4 insults
    340. CYP2E1 regulation by benzene and other small organic chemicals in rat liver and peripheral lymphocytes
    341. CYP2E1 rs2031920, COMT rs4680 polymorphisms, cigarette smoking, alcohol use and lung cancer risk in a Japanese population
    342. CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking
    343. CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls
    344. CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis
    345. CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians
    346. CYP2E1 RsaⅠpolymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking
    347. CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies
    348. CYP2E1 Rsai/Psti polymorphisms contributed to oral cancer susceptibility: A meta-analysis
    349. CYP2E1 substrate inhibition mechanistic interpretation through an effector site for monocyclic compounds
    350. CYP2E1 substrate inhibition. MECHANISTIC INTERPRETATION THROUGH AN EFFECTOR SITE FOR MONOCYCLIC COMPOUNDS.
    351. CYP2E1 substrate inhibition..
    352. CYP2E1 T7632A and 9-bp insertion polymorphisms and colorectal cancer risk: a meta-analysis based on 4,592 cases and 5,918 controls
    353. CYP2E1 VNTR genotyping associated to anti–tuberculosis drug-induced hepatotoxicity
    354. CYP2E1 VNTR polymorphisms and hepatocarcinoma: a gender-specific correlation
    355. CYP2E1* 1D regulatory polymorphism: association with alcohol and nicotine dependence
    356. CYP2E1* 5B, CYP2E1* 6, CYP2E1* 7B, CYP2E1* 2, and CYP2E1* 3 allele frequencies in Iranian populations
    357. CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug‐induced hepatotoxicity: a nested case–control study
    358. CYP2E1, oxidative stress and MAPK signaling pathways in alcohol-induced hepatotoxicity
    359. CYP2E1, oxidative stress, post-translational modifications and lipid metabolism
    360. CYP2E1: biochemistry, toxicology, regulation and function in ethanol-induced liver injury
    361. CYP2E1: from ash to nash
    362. CYP2E1: Mechanism of induction by isoniazid and role in acetaminophen oxidation.
    363. CYP2E1: the anesthesia enzyme
    364. CYP2E1-and TNFalpha/LPS-induced oxidative stress and MAPK signaling pathways in alcoholic liver disease
    365. CYP2E1–Biochemical and Toxicological Aspects and Role in Alcohol-Induced Liver Injury
    366. CYP2E1-catalyzed alcohol metabolism: Role of oxidant generation in interferon signaling, antigen presentation and autophagy
    367. CYP2E1-catalyzed oxidation contributes to the sperm toxicity of 1-bromopropane in mice
    368. CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis
    369. CYP2E1-dependent benzene toxicity: the role of extrahepatic benzene metabolism
    370. CYP2E1-dependent bioactivation of 1, 1-dichloroethylene in murine lung: formation of reactive intermediates and glutathione conjugates
    371. CYP2E1-dependent bioactivation of 1, 1-dichloroethylene to reactive intermediates in murine and human lung and liver microsomes.
    372. CYP2E1-DEPENDENT BIOACTIVATION OF 191
    373. CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid
    374. CYP2E1-dependent hepatotoxicity and oxidative damage after ethanol administration in human primary hepatocytes
    375. CYP2E1-dependent oxidative stress and toxicity: role in ethanol-induced liver injury
    376. CYP2E1-dependent toxicity and oxidative stress in HepG2 cells
    377. CYP2E1-dependent toxicity and up-regulation of antioxidant genes
    378. CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane
    379. CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity
    380. CYP2E1‐mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells
    381. CYP2E1-mediated oxidative stress regulates HO-1 and GST expression in maneb-and paraquat-treated rat polymorphonuclear leukocytes
    382. Cytochemical Localization of the Acetone-lnducible Cytochrome P-450 Isoform, CYP2E1 in Murine Colonic Epithelium
    383. Cytochrome b5 coexpression increases the CYP2E1-dependent mutagenicity of dialkylnitrosamines in methyltransferase-deficient strains of Salmonella typhimurium
    384. Cytochrome b5 reductase and cytochrome b5 support the CYP2E1-mediated activation of nitrosamines in a recombinant Ames test
    385. Cytochrome CYP2E1 is critical for joint effects of alcohol and lipids on hepatocellular steatosis and inflammation
    386. Cytochrome CYP2E1 phenotyping and genotyping in the evaluation of health risks from exposure to polluted environments
    387. Cytochrome P450 2E1 (CYP2E1) is essential for acrylonitrile metabolism to cyanide: comparative studies using CYP2E1-null and wild-type mice
    388. Cytochrome P450 2E1 (CYP2E1) is the principal enzyme responsible for urethane metabolism: comparative studies using CYP2E1-null and wild-type mice
    389. Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells
    390. Cytochrome P450 2E1 (CYP2E1)-dependent production of a 37-kDa acetaldehyde–protein adduct in the rat liver
    391. Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance
    392. Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol‐induced oxidative DNA damage in rodent liver
    393. Cytochrome P450 Genes (CYP2E1 and CYP1A1) Variants and Susceptibility to Chronic Hepatitis B Virus Infection
    394. Cytochrome P450 Reductase-null Mice as an Animal Model to Study Electron Transfer Pathways in Cholesterol Synthesis and CYP2E1-mediated Drug Metabolism
    395. Cytochrome P4502E1 (CYP2E1) expression in peripheral blood lymphocytes: evaluation in hepatitis C and diabetes
    396. Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease.
    397. Cytochrome P450IIE1 (CYP2E1) is induced by skatole and this induction is blocked by androstenone in isolated pig hepatocytes
    398. Cytochrome p-450-mediated differential oxidative modification of proteins: albumin, apolipoprotein E, and CYP2E1 as targets
    399. D2-receptor-linked signaling pathways regulate the expression of hepatic CYP2E1
    400. Decreased CYP2E1 mRNA expression in human leucocytes in patients with fibrotic and inflammatory lung diseases
    401. Decreased protein and mRNA expression of ER stress proteins GRP78 and GRP94 in HepG2 cells over-expressing CYP2E1
    402. dehydrogenase 2, cytochrome p450 2E1 for liver cancer risk in HCV antibody-positive japanese patients and the variations of CYP2E1 mRNA expression levels in the …
    403. Depletion of cytosolic or mitochondrial thioredoxin increases CYP2E1-induced oxidative stress via an ASK-1–JNK1 pathway in HepG2 cells
    404. Depression of glutathione content, elevation of CYP2E1-dependent activation, and the principal determinant of the fasting-mediated enhancement of 1, 3-dichloro-2 …
    405. Detection and characterization of novel polymorphisms in the CYP2E1 gene.
    406. Detection of autoantibodies against cytochrome P450 2E1 (CYP2E1) in patients with recurrent hepatitis C
    407. Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C
    408. Detection of CYP2E1, a genetic biomarker of susceptibility to benzene metabolism toxicity in immortal human lymphocytes derived from the Han Chinese population
    409. Determination of the activity of human hepatic cytochromes P450 CYP2C8/9, CYP2E1
    410. Development and properties of HepG2 cells that constitutively express CYP2E1
    411. Development of a non-high pressure liquid chromatography assay to determine [14C] chlorzoxazone 6-hydroxylase (CYP2E1) activity in human liver microsomes
    412. Development of an IgY antibody-based immunoassay for the screening of the CYP2E1 inhibitor/enhancer from herbal medicines
    413. Developmental Expression of CYP2E1 in the Human Liver: Hypermethylation Control of Gene Expression During the Neonatal Period
    414. Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality
    415. Diallylsulfide and allylmethylsulfide are uniquely effective among organosulfur compounds in inhibiting CYP2E1 protein in animal models
    416. Dichloroacetic acid treatment increases hepatic CYP2E1 in male and female rats
    417. Dietary aflatoxin B1 intake, genetic polymorphisms of CYP1A2, CYP2E1, EPHX1, GSTM1, and GSTT1, and gastric cancer risk in Korean
    418. Dietary lipids affect human ethanol-inducible CYP2E1 gene expression in vivo in mononuclear cells
    419. Dietary omega-3 polyunsaturated fatty acids alter fatty acid composition of lipids and CYP2E1 expression in rat liver tissue
    420. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites
    421. Different CYP2E1 genotypes and alcoholic liver disease.
    422. Different regulation and expression of the human CYP2E1 gene due to the Rsal polymorphism in the 5′-flanking region
    423. Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol
    424. Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver
    425. Differential effects of dietary fatty acids on the regulation of CYP2E1 and protein kinase C in human hepatoma HepG2 cells
    426. Differential expression of cytochrome P4502E1 (CYP2E1) in Morris hepatomas and livers of tumor bearing rats.
    427. Differential expression profile of cytochrome p450 2E1 (CYP2E1) related genes associated with carbon tetrachloride-induced hepatotoxicity
    428. Differential in vivo effects of α‐naphthoflavone and β‐naphthoflavone on CYP1A1 and CYP2E1 in rat liver, lung, heart, and kidney
    429. Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake
    430. Differential metabolism of acrylonitrile to cyanide is responsible for the greater sensitivity of male vs female mice: role of CYP2E1 and epoxide hydrolases
    431. Differential Modulation of CYP2E1 Activity by cAMP-Dependent Protein Kinase upon Ser129Replacement
    432. Differential role of CYP2E1 binders and isoniazid on CYP2E1 protein modification in NADPH-dependent microsomal oxidative reactions: free radical scavenging …
    433. Differential role of CYP2E1-mediated metabolism in the lethal and vestibulotoxic effects of cis-crotononitrile in the mouse
    434. Diminished CYP2E1 expression and formation of 2-S-glutathionyl acetate, a glutathione conjugate derived from 1, 1-dichloroethylene epoxide, in murine lung tumors
    435. Direct sequencing and comprehensive screening of genetic polymorphisms on CYP2 family genes (CYP2A6, CYP2B6, CYP2C8, and CYP2E1) in five ethnic …
    436. Distribution and differential induction of CYP2E1 by ethanol and acetone in the mesocorticolimbic system of rat
    437. Distribution of ADH1B, ALDH2, CYP2E1∗ 6, and CYP2E1∗ 7B genotypes in Turkish population
    438. Distribution of cytochrome CYP2E1 in murine liver after ethanol and acetone administration
    439. DLPC attenuates alcohol-induced cytotoxicity in HepG2 cells expressing CYP2E1
    440. DNA damage and cytotoxicity in pancreatic β-cells expressing human CYP2E1
    441. DNA damage in peripheral blood lymphocytes and association with polymorphisms in the promoter region of the CYP2E1 gene in alcoholics from Central Brazil
    442. DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood …
    443. Do Endogenous Volatile Organic Chemicals Measured in Breath Reflect and Maintain CYP2E1 Levelsin Vivo?
    444. Docosahexaenoic acid induces apoptosis in CYP2E1-containing HepG2 cells by activating the c-Jun N-terminal protein kinase related mitochondrial damage
    445. Does CYP2E1 play a major role in the aggravation of isoniazid toxicity by rifampicin in human hepatocytes?
    446. Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies
    447. Downregulation of the CYP2E1 ameliorates oxidative stress and apoptosis
    448. Down-regulation of the expression of alcohol dehydrogenase 4 and CYP2E1 by the combination of α-endosulfan and dioxin in HepaRG human cells
    449. Drinking Water Chlorination By-Products and Intra-Uterine Growth Restriction: is there an effect modification of the CYP2E1 G1259C gene polymorphism?
    450. Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans
    451. e0048 CYP2E1 increases oxidative stress and induces apoptosis of cardio myocytes in transgenic mice
    452. Early Alcoholic Liver Injury: Formation of Protein Adducts with Acetaldehyde and Lipid Peroxidation Products, and Expression of CYP2E1 AND CYP3A
    453. Effect of {gamma}-irradiation and mitomycin C (MMC) on CYP2B1 and CYP2E1 activities in rat hepatic microsomes in vitro
    454. Effect of 1-aminobenzotriazole on the in vitro metabolism and single-dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats
    455. effect of acidic polysaccharide from Schisandra chinensis on acute ethanol-induced liver injury through reducing CYP2E1-dependent oxidative stress
    456. Effect of ALDH2 and CYP2E1 Gene Polymorphisms on Drinking Behavior and Alcoholic Liver Disease in Japanese Male Workers
    457. Effect of ammonium pyrrolidine dithiocarbamate (PDTC) on NF-κB activation and CYP2E1 content of rats with immunological liver injury
    458. Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes
    459. Effect of BI-1 on insulin resistance through regulation of CYP2E1
    460. Effect of Capsosiphon fulvescens on ethanol-induced liver damage in HepG2 cells over expressing CYP2E1
    461. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N‐acetyltransferase in healthy human subjects
    462. Effect of cigarette smoke on hepatic and pulmonary cytochromes P450 in mouse: evidence for CYP2E1 induction in lung
    463. Effect of CYP2E1 gene deletion in mice on expression of microsomal epoxide hydrolase in response to VCD exposure
    464. Effect of CYP2E1 genetic polymorphisms on susceptibility of aplastic anemia
    465. Effect of CYP2E1 induction by ethanol on the immunotoxicity and genotoxicity of extended low-level benzene exposure
    466. Effect of CYP2E1 polymorphism on DNA stability and lung cancer susceptibility
    467. Effect of CYP2E1 Ras I Genotypes on CYP2E1 Enzyme Activity and DNA Damage of Immortalized Human Lymphocytes Induced by Phenol
    468. Effect of different radix polygoni multiflori preparata on CYP2E1 mRNA expression in rat liver [J]
    469. Effect of disulfiram‐mediated CYP2E1 inhibition on the disposition of vesnarinone
    470. Effect of Er Chen Tang on CYP2E1 and Mitochondrial Energy Metabolism in Nonalcoholic Fatty Liver Disease
    471. Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation, and serum protein adduct formation in relation to liver pathology pathogenesis
    472. Effect of exposure to benzo [a] pyrene on SODs, CYP1A1/1A2-and CYP2E1 immunopositive proteins in the blood clam
    473. Effect of exposure to benzo [a] pyrene on SODs, CYP1A1/1A2-and CYP2E1 immunopositive proteins in the blood clam Scapharca inaequivalvis
    474. Effect of fasting and obesity in humans on the 6‐hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity
    475. Effect of flavonoids extract from apocynum venetum tea on CYP2E1 in mice.
    476. Effect of Ganzheng formula on CYP2E1, adiponectin and TNF-α in NAFLD rats
    477. Effect of Gegen Powder on CYP450 Content of Liver Microsomal and Activity of CYP2E1 in Mice Acute Alcohol-induced Liver Injury
    478. Effect of genetic polymorphisms of toxin metabolic enzyme CYP2E1 on metabolism of styrene
    479. Effect of high‐dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe
    480. Effect of jujube on the expression of CYP2E1 and TNF-alpha in the hepatic tissue of mice with alcoholic liver disease
    481. Effect of Leflunomide on the content of cytochrome P450 enzyme and CYP2E1 mRNA expression of mice with acute chemical injury [J]
    482. Effect of methacrylonitrile on cytochrome P-450 2E1 (CYP2E1) expression in male F344 rats
    483. EFFECT OF NARINGIN ON THE ACTIVITY OF HUMAN LIVER MICROSOMES CYP2E1 USING PROBE DRUG METHOD
    484. Effect of neferine on CYP450 total enzyme and CYP3A1, CYP2D1, CYP2E1 mRNA in Rats
    485. Effect of oleanolic acid on CYP1A2, CYP2E1 and CYP3A4 activity in healthy subjects
    486. Effect of piperine on CYP2E1 enzyme activity of chlorzoxazone in healthy volunteers
    487. Effect of quercetin on CYP1A2, CYP2E1, CYP3A2 activities and its inhibitory mechanism studies in rat liver microsomes
    488. Effect of Salviae Miltiorrhizae Radix et Rhizoma and Carthami Flos before and after compatibility on activities of CYP1A2, CYP2E1, and CYP3A4 from rat liver …
    489. Effect of Sanchi on expression of hepatic CYP2E1 in liver tissues in rats with alcoholic liver disease [J]
    490. Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1
    491. Effect of starvation and acetone on the enzyme systems of biotransformation and toxicity of xenobiotics–CYP2E1 substrates in rats
    492. Effect of status epilepticus and antiepileptic drugs on CYP2E1 brain expression
    493. Effect of Sulfamethoxazole, Glycyrrhiza Uralensis Fisc and Fisch Fructus Forsythiae on Cytochrome CYP2E1 in Paralichthys Olivaceus by Probe Drugs
    494. Effect of sulfur dioxide inhalation on CYP2B1/2 and CYP2E1 in rat liver and lung
    495. Effect of temperature on carp CYP2E1-like isoform activity.
    496. Effect of TFHL on expression of CYP2E1 in liver tissue of rats with NASH.
    497. Effect of the CYP2E1 genotype on vinyl chloride monomer-induced liver fibrosis among polyvinyl chloride workers
    498. Effect of the South African traditional meat, biltong, on cancer-associated enzymes CYP2E1 and CYP1A2
    499. EFFECT OF TOTAL ALKALOIDES OF ACONITUM EXCELSUM REICHB ON CYP2E1 METABOLISM ACTIVITY IN MORPHINE DEPENDENT RATS [J]
    500. Effect of total alkaloids of Rubus alceaefolius poiron on gene expressions of CYP2E1 and CYP3A1 in rats with acute liver injury
    501. Effect of water miscible organic solvents on p-nitrophenol hydroxylase (CYP2E1) activity in rat liver microsomes
    502. Effect of XiaozhiHugan Capsule on Pathologic Changes and CYP2E1 Gene Expression of Rats with Non-alcoholic Fatty Liver [J]
    503. Effect of γ-irradiation and mitomycin C (MMC) on CYP2B1 and CYP2E1 activities in rat hepatic microsomes in vitro
    504. Effects of acrylamide on oxidant/antioxidant parameters and CYP2E1 expression in rat pancreatic endocrine cells
    505. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1, 3‐dimethyluric …
    506. Effects of ALDH2, CYP1A1, and CYP2E1 genetic polymorphisms and smoking and drinking habits on toluene metabolism in humans
    507. Effects of aqueous extract of Polygoni Multiflori Radix and its main constituents on expression of mRNA of CYP1A2, CYP2C9, and CYP2E1 in human liver L02 cells
    508. Effects of benzene on liver, kidney and lung cyp1a, cyp2b4, CYP2E1 and cyp3a6 mrna, protein level, and drug metabolizing enzyme activities and toxicity in diabetic …
    509. Effects of blueberry on ultrastructural and expression of cytochrome CYP2E1 in rats with immune hepatic fibrosis
    510. Effects of chlorinated aliphatic hydrocarbons on the fidelity of cell division in human CYP2E1 expressing cells
    511. Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma
    512. Effects of Danshen and Its Active Components on Rat CYP2E1 Expression and Metabolism of Model CYP2E1 Probe Substrate
    513. Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N …
    514. Effects of dietary fat composition on activities of the microsomal ethanol oxidizing system and ethanol‐inducible cytochrome P450 (CYP2E1) in the liver of rats …
    515. Effects of Environmental Carcinogens and Genetic Polymorphisms of CYP2E1 and NAT2 on Gastric Carcinogenesis.
    516. Effects of environmental factors on extrahepatic CYP2E1 gene expression in mice
    517. Effects of ethanol on CYP2E1 levels and related oxidative stress using a standard balanced diet
    518. Effects of flavonoids in Lysimachia clethroides duby on the activities of cytochrome P450 CYP2E1 and CYP3A4 in rat liver microsomes
    519. Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats
    520. Effects of Ganzhengfufang on the PPARγ and CYP2E1 in the rat with nonalcoholic fatty liver disease
    521. Effects of genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 on the urinary levels of 1-hydroxypyrene and 2-naphthol in aircraft maintenance workers
    522. Effects of GSTM1 and CYP2E1 Genetic Polymorphism and Drinking on DNA Damage among Workers Exposed to Phenol and Acetone
    523. Effects of metadoxine on the expression of CYP2E1 in liver tissue of male rats with alcoholic fat liver [J]
    524. Effects of mitomycin (MMC) and {gamma}-ray irradiation on cytochrome p450 content and activities of CYP2B1 and CYP2E1 in rats
    525. Effects of mitomycin (MMC) and γ-ray irradiation on cytochome p450 content and activities of CYP2B1and CYP2E1 in rats [J]
    526. Effects of mitomycin (MMC) and γ-ray irradiation on cytochrome p450 content and activities of CYP2B1 and CYP2E1 in rats
    527. Effects of N-acetyltransferase 2 (NAT2), CYP2E1 and Glutathione-S-transferase (GST) genotypes on the serum concentrations of isoniazid and metabolites in …
    528. Effects of nonyphenol exposure during pregnant and lactation period on expressions of CYP2E1 mRNA and protein of hepatic tissues in offspring rats
    529. Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations
    530. Effects of Purified Glycerol from Biodiesel on Cyp1a1 and CYP2E1 Expressions in CBA/CA Mice
    531. Effects of rifampin on CYP2E1-dependent hepatotoxicity of isoniazid in rats
    532. Effects of SNPs (CYP1B1* 2 G355T, CYP1B1* 3 C4326G, and CYP2E1* 5 G-1293C), smoking, and drinking on susceptibility to laryngeal cancer among Han …
    533. Effects of steady-state lasofoxifene on CYP2D6-and CYP2E1-mediated metabolism
    534. EFFECTS OF STRUCTURALLY AND FUNCTIONALLY DIVERSE GROUP OF PHYTOCHEMICALS ON ANILINE HYDROXYLATION (CYP2E1) OF CONTROL AND …
    535. Effects of SU-MIAN-XIN on CYP3A1 and CYP2E1 in Rat Primary Cultured Hepatocytes
    536. Effects of the activities and mRNA level of CYP2E1 in mouse liver microsomal by Folium Isatidis
    537. Effects of the ADH3, CYP2E1, and GSTP1 genetic polymorphisms on their expressions in Caucasian lung tissue
    538. Effects of the plant phenolic quercetin on protein and mRNA CYP1A1, CYP2E1, NQO1 and GST enzymes in colon cancer cell line SW620
    539. Effects of Trichloroethylene Toxicity on Normal Human Liver Cells and Hepatocytes With CYP2E1 Gene Overexpression
    540. Effects of Zhenyuan Capsule on Cytochrome P450 Enzymes CYP1A2, CYP3A4 and CYP2E1
    541. Ekspresija CYP2E1 u testisima štakora i alkoholom prouzrokovane promjene indeksa spermatogeneze i kolagena tipa I
    542. Elimination rate of 6-hydroxychlorzoxazone in urine as a non-invasive evaluation of cytochrome CYP2E1 activity. Lack of relationship to smoking
    543. Elucidation of CYP2E1 5′ regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer
    544. End-product inhibition of skatole-metabolising enzymes CYP1A, CYP2A19 and CYP2E1 in porcine and piscine hepatic microsomes
    545. Environmental exposure to benzene: evaluation of urinary S-PMA and polymorphism (CYP2E1-1293G> C and NQO1 609C> T) in Campos Elíseos residents …
    546. ‐en‐Y gastric bypass surgery influenced pharmacokinetics of several drugs given as a cocktail with the highest impact observed for CYP1A2, CYP2C8 and CYP2E1 …
    547. Ephedra water decoction and cough tablets containing ephedra and liquorice induce CYP1A2 but not CYP2E1 hepatic enzymes in rats
    548. Epididymal CYP2E1 plays a critical role in acrylamide-induced DNA damage in spermatozoa and paternally mediated embryonic resorptions
    549. Epilobium hirsutum alters xenobiotic metabolizing CYP1A1, CYP2E1, NQO1 and GPx activities, mRNA and protein levels in rats
    550. Epoxide formation from diallyl sulfone is associated with CYP2E1 inactivation in murine and human lungs
    551. Establishment and toxicological application of a cell line expressing human CYP2E1
    552. Establishment of a p-nitrophenol oxidation-based assay for the analysis of CYP2E1 activity in intact hepatocytes in vitro
    553. Establishment of model with exogenous human CYP2E1 expression and inducement of substrates
    554. Estrogen-related receptor γ controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol
    555. Ethanol and arachidonic acid produce toxicity in hepatocytes from pyrazole-treated rats with high levels of CYP2E1
    556. Ethanol enhanced the genotoxicity of acrylamide in human, metabolically competent HepG2 cells by CYP2E1 induction and glutathione depletion
    557. CYP2E1_by_protein_stabilization_Role_of_ubiquitin_conjugation_in_the_rapid_degradation_of_CYP2E1/links/58500e2508aed95c250b7b96.pdf”>Ethanol Induces CYP2E1 by Protein Stabilization
    558. Ethanol induces CYP2E1 by protein stabilization role of ubiquitin conjugation in the rapid degradation of CYP2E1
    559. Ethanol induction of CYP2A5: permissive role for CYP2E1
    560. Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway
    561. CYP2E1_and_catalase_influence_ethanol_sensitivity.4.aspx”>Ethanol intake and ethanol-induced locomotion and locomotor sensitization in CYP2E1 knockout mice
    562. Ethanol self-administration and nicotine treatment induce brain levels of CYP2B6 and CYP2E1 in African green monkeys
    563. Ethanol withdrawal induced CYP2E1 degradation in vivo, blocked by proteasomal inhibitor PS-341
    564. Ethanol-induced oxidative DNA damage and CYP2E1 expression in liver tissue of Aldh2 knockout mice
    565. Ethanol-induced oxidative stress is associated with EGF receptor phosphorylation in MCF-10A cells overexpressing CYP2E1
    566. Ethanol‐induced oxidative stress via the CYP2E1 pathway disrupts adiponectin secretion from adipocytes
    567. Ethanol-induction of cytochrome P450 2A5: permissive role for CYP2E1
    568. Ethanol‐mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA‐lesions
    569. Ethanol-mediated transplacental induction of CYP2E1 in fetal rat liver
    570. Ethanol‐related cytotoxicity catalyzed by CYP2E1‐dependent generation of reactive oxygen intermediates in transduced HepG2 cells
    571. Ethnic susceptibility to lung cancer: differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms between French Caucasian and Chilean populations
    572. CYP2E1_gene__polymorphism.2.aspx”>Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese
    573. Evaluation of activity of hepatic CYP2E1 following administration of Radix et Rhizoma Rhei by probe drug in rats [J]
    574. Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations
    575. Evaluation of influence of Andrographis paniculata on activities of CYP1A2, CYP3A4, CYP2E1 and CYP2C19 genotypes in chickens by multiple cytochrome P450 …
    576. Evidence for a tissue-specific induction of cutaneous CYP2E1 by dexamethasone
    577. Evidence for the Existence of Two Human CYP2E1 cDNAs Using Different Polyadenylation Signals
    578. Evidence of association of the CYP2E1 genetic polymorphism with micronuclei frequency in human peripheral blood
    579. Evolution of camel CYP2E1 and its associated power of binding toxic industrial chemicals and drugs
    580. Exacerbation of benzene pneumotoxicity in connexin 32 knockout mice: enhanced proliferation of CYP2E1-immunoreactive alveolar epithelial cells
    581. Examination of a CYP2E1 repeat polymorphism in a monkey model of alcohol abuse
    582. Experimental study on effect of Erchen decoction and Taohongsiwu decoction on CYP2E1 activities in non-alcoholic fatty liver rats
    583. Experimental study on the effects of combined administration of Shuanghuanglian powder for injection and levofloxacin hydrochloride injection on CYP2E1 in mice
    584. exposure to styrene: modulation of cytogenetic damage and levels of urinary metabolites of styrene by polymorphisms in genes CYP2E1, EPHX1, GSTM1, GSTT1 …
    585. Expression and activity of CYP2E1 in circulating lymphocytes are not altered in diabetic individuals
    586. Expression and regulation of cytochrome P450 CYP2E1 in the minipig
    587. Expression of CYP2E1 by human monocyte‐derived macrophages
    588. Expression of CYP2E1 during human fetal development: methylation of the CYP2E1 gene in human fetal and adult liver samples
    589. Expression of CYP2E1 gene in liver tissue in patients with hepatic cirrhosis and obstuctive jaundice
    590. Expression of CYP2E1 gene in paint workers occupationally exposed to organic solvents
    591. Expression of CYP2E1 in Human Lung and Kidney during Development and in Full‐Term Placenta: A Differential Methylation of the Gene is Involved in the …
    592. Expression of CYP2E1 in human nasopharynx and its metabolic effect in vitro
    593. Expression of CYP2E1 increases oxidative stress and induces apoptosis of cardiomyocytes in transgenic mice
    594. Expression of cytochrome P450 enzymes CYP1A1, CYP1B1, CYP2E1 and CYP4B1 in cultured transitional cells from specimens of the human urinary tract and from …
    595. Expression of human CYP2E1 in insect cells using bac-to-bac expression system
    596. Expression, catalytic activity, and inducibility of cytochrome P450 2E1 (CYP2E1) in the rat central nervous system
    597. Extrahepatic metabolism by CYP2E1 in PBPK modeling of lipophilic volatile organic chemicals: impacts on metabolic parameter estimation and prediction of dose …
    598. Fast CYP2E1 genotyping using automated fluorescent detection.
    599. Featured structure-activity relationships for some tri-and tetrachlorobiphenyls in human CYP2E1-activated mutagenicity—Impact of the extent of ortho-chlorination
    600. Ferric citrate CYP2E1-independently promotes alcohol-induced apoptosis in HepG2 cells via oxidative/nitrative stress which is attenuated by pretreatment with …
    601. final hydrogenated metabolites of curcumin, possess superior hepatic-protective effect against acetaminophen-induced liver injury: role of CYP2E1 and Keap1-Nrf2 …
    602. for the Expression of Recombinant Human Cytochrome P450s inEscherichia coliUsing Bacterial Signal Peptides: Expression of CYP3A4, CYP2A6, and CYP2E1
    603. Formation of multiple CYP2E1 complexes affects activity
    604. Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations
    605. Frequency distribution of high risk alleles of CYP2C19, CYP2E1, CYP3A4 genes in Haryana population
    606. Functional analyses of the pig CYP2E1 promoter and identification of the transcription factors required for CYP2E1 expression
    607. CYP2E1_methylation_in.1048.aspx”>Functional correlate of CYP2E1 methylation in chronic exposure to VOCs: promoter methylation vs. 5’UTR methylation
    608. Functional CYP2E1 is required for substantial in vivo formation of 2,5-hexanedione from n-hexane in the mouse
    609. Functional polymorphism in porcine CYP2E1 gene: Its association with skatole levels
    610. Functional polymorphism of CYP2E1 gene and alcohol use disorders in a Tibetan population.
    611. Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1
    612. Garlic oil alleviated ethanol-induced fat accumulation via modulation of SREBP-1, PPAR-α, and CYP2E1
    613. Gene copy number variation analysis reveals dosage-insensitive expression of CYP2E1
    614. Gene CYP2E1 expression in mouse liver cells exposed to low-dose radiation
    615. Gene Structure and Multiple Regulations of the Ethanol-Inducible Cytochrome P45O2E1 (CYP2E1) Subfamily
    616. Gene–environmental interactions between alcohol-drinking behavior and ALDH2 and CYP2E1 polymorphisms and their impact on micronuclei frequency in human …
    617. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone
    618. Genetic Interaction between NAT2, GSTM1, GSTT1, CYP2E1, and Environmental Factors Is Associated with Adverse Reactions to Anti-Tuberculosis Drugs
    619. Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in a Chinese Tibetan population
    620. Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in Chinese Han populations from four different geographic areas of Mainland China
    621. Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity
    622. Genetic Polymorphism in Promoter Sequence of CYP2E1 Gene in Paint Manufacturing Workers Exposed to Volatile Organic Compounds
    623. Genetic polymorphism of CYP2D6, CYP2E1 and susceptibility to chronic occupational manganism poisoning [J]
    624. Genetic polymorphism of CYP2E1 and digestive tract alcohol damage among Polish individuals
    625. Genetic polymorphism of CYP2E1, ADH2, and ALDH2 in Mexican-Americans
    626. CYP2E1,_GSTT1_M1_and_NQO1.905.aspx”>Genetic Polymorphism of CYP2E1, GSTT1/M1 and NQO1 on Biomarker of Urinary Spma Among Benzene-Exposed Workers
    627. Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter …
    628. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients
    629. Genetic polymorphism of human CYP2E1: characterization of two variant alleles
    630. Genetic polymorphism of human CYP2E1: new allels detected in exons and exon-intron junctions
    631. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population
    632. Genetic polymorphism of the CYP2E1 gene and susceptibility to Parkinson’s disease in Taiwanese
    633. Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population
    634. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the …
    635. Genetic polymorphisms in GSTM1,-P1,-T1, and CYP2E1 and the risk of adult brain tumors
    636. Genetic Polymorphisms of ADH1C and CYP2E1 and Risk of Oral Squamous Cell Carcinoma
    637. Genetic polymorphisms of alcohol inducible CYP2E1 in Turkish population
    638. Genetic Polymorphisms of CYP1A1, CYP2E1, and GSTM1 Genes: Susceptibility to Colon Cancer
    639. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer
    640. Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile.
    641. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer
    642. Genetic polymorphisms of CYP2E1 and GSTM1 and T1 on susceptibility to esophageal cancer in Huaian, China
    643. Genetic polymorphisms of CYP2E1 and GSTM1 loci and susceptibility to anti-tuberculosis drug-induced hepatotoxicity
    644. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study
    645. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study
    646. Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women
    647. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer.
    648. Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population
    649. Genetic Polymorphisms of Genes Coding to Alcohol‐Metabolizing Enzymes in Western Mexicans: Association of CYP2E1*c2/CYP2E1*5B Allele with Cirrhosis and …
    650. Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis
    651. Genetic Polymorphisms of NAT2, CYP2C9, CYP2C19, CYP2D6 and CYP2E1, and Antituberculosis Drugs Induced Maculopapular Eruption
    652. Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients
    653. Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based …
    654. Genetic regulation of liver microsomal CYP2E1 activity among strains of the viviparous fishes Poeciliopsis occidentalis and Poeciliopsis lucida
    655. Genetic Repeat Polymorphism in the Regulating Region of CYP2E1: Frequency and Relationship With Enzymatic Activity in Alcoholics
    656. Genetic Variability in CYP2E1 and Catalase Gene Among Currently and Formerly Alcohol-Dependent Male Subjects
    657. Genetic variants of ALDH2-rs671 and CYP2E1-rs2031920 contributed to risk of hepatocellular carcinoma susceptibility in a Chinese population
    658. Genetic variation in the temperature dependence of liver microsomal CYP2E1 activity, within and between species of the viviparous fish Poeciliopsis
    659. Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population
    660. Genotoxicity of 1‐methylpyrene and 1‐hydroxymethylpyrene in chinese hamster V79‐derived cells expressing both human CYP2E1 and SULT1A1
    661. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population
    662. Genotype and allele frequencies of polymorphic cytochromes P450 CYP1A2 and CYP2E1 in Mexicans
    663. Genotype and allelic frequencies of CYP2E1* 5B polymorphism in the southwest population of Iran
    664. Genotype and phenotype polymorphisms of NAT2 and CYP2E1 in the Han Chinese pediatric population
    665. Genotype Polymorphisms of NAT2 and CYP2E1 Genes Associated with Drug Induced Liver Injury (DILI) in Indonesian Tuberculosis Patients
    666. Global Analysis of Protein− Protein Interactions Reveals Multiple CYP2E1− Reductase Complexes
    667. Global patterns of variation in allele and haplotype frequencies and linkage disequilibrium across the CYP2E1 gene
    668. Glucose inhibition of the induction of CYP2E1 mRNA expression by ethanol in FGC-4 cells
    669. Glucoside exacerbates acetaminophen-induced hepatotoxicity by inducing hepatic expression of CYP2E1, CYP3A4 and CYP1A2
    670. Glutathione depletion in CYP2E1-expressing liver cells induces toxicity due to the activation of p38 mitogen-activated protein kinase and reduction of nuclear factor-κB …
    671. Glycyrrhetinic acid prevents acetaminophen-induced acute liver injury via the inhibition of CYP2E1 expression and HMGB1-TLR4 signal activation in mice
    672. Green tea polyphenol epigallocatechin-3-gallate protects HepG2 cells against CYP2E1-dependent toxicity
    673. Growth retardation of fetal rats exposed to nicotine in utero: Possible involvement of CYP1A1, CYP2E1, and P‐glycoprotein
    674. GSTT1 and CYP2E1 polymorphisms and trihalomethanes in drinking water: effect on childhood leukemia.
    675. GSTT1, GSTM1 and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population
    676. GYKI-47261, a new AMPA [2-amino-3-(3-hydroxymethylisoxazole-4-yl) propionic acid] antagonist, is a CYP2E1 inducer
    677. Halothane inhalation inhibits the metabolism of chlorzoxazone, a substrate for CYP2E1, in rabbits
    678. HBx inhibits CYP2E1 gene expression via downregulating HNF4α in human hepatoma cells
    679. Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years
    680. Hepatic and pulmonary microsomal benzene metabolism in CYP2E1 knockout mice
    681. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling
    682. Hepatoprotective effect of 10% ethanolic extract from Curdrania tricuspidata leaves against ethanol-induced oxidative stress through suppression of CYP2E1
    683. Hepatoprotective Effect of Punica granatum Seed Oil Extract on Paracetamol Intoxication in Rat Via Inhibory Effect of CYP2E1
    684. Hepatotoxicity Mediated by Pyrazole (CYP2E1) Plus TNF-α Treatment Occurs in jnk2−/− but not in jnk1−/− Mice
    685. Heteromeric complex formation between CYP2E1 and CYP1A2: evidence for the involvement of electrostatic interactions
    686. High CYP2E1 activity aggravates hepatofibrosis by limiting macrophage polarization towards the M2 phenotype
    687. High CYP2E1 activity correlates with hepatofibrogenesis induced by nitrosamines
    688. High dose lycopene supplementation increases hepatic CYP2E1 protein and TNF‐α expression in alcohol fed rats
    689. High inducibility of mouse renal CYP2E1 gene by tobacco smoke and its possible effect on DNA single strand breaks
    690. Higher sensitivity of female cells to ethanol: methylation of DNA lowers CYP2E1, generating more ROS
    691. Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1
    692. Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells
    693. Homology modelling of human CYP2E1 based on the CYP2C5 crystal structure: investigation of enzyme–substrate and enzyme–inhibitor interactions
    694. Hormone controlled phosphorylation and degradation of CYP2B1 and CYP2E1 in isolated rat hepatocytes
    695. How mutations affecting the ligand-receptor interactions: a combined MD and QM/MM calculation on CYP2E1 and its two mutants
    696. Human CYP2A6, CYP2B6, and CYP2E1 atropselectively metabolize polychlorinated biphenyls to hydroxylated metabolites
    697. Human CYP2E1 is regulated by miR-378
    698. Human CYP2E1 mediates the formation of glycidamide from acrylamide
    699. Human CYP2E1-activated mutagenicity of dioxin-like PCBs 105 and 118—Experimental data consistent with molecular docking results
    700. Human CYP2E1-dependent and human sulfotransferase 1A1-modulated induction of micronuclei by benzene and its hydroxylated metabolites in Chinese hamster …
    701. Human CYP2E1‐dependent mutagenicity of benzene and its hydroxylated metabolites in V79‐derived cells: Suppression and enhancement by ethanol pretreatment
    702. Human CYP2E1-dependent mutagenicity of mono-and dichlorobiphenyls in Chinese hamster (V79)-derived cells
    703. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype.
    704. Human hepatic CYP2E1 expression during development
    705. Human hepatocytes are protected from ethanol-induced cytotoxicity by DADS via CYP2E1 inhibition
    706. Human placental lactogen induces CYP2E1 expression via PI 3-kinase pathway in female human hepatocytes
    707. Human variability for metabolic pathways with limited data (CYP2A6, CYP2C9, CYP2E1, ADH, esterases, glycine and sulphate conjugation)
    708. Hypomethylation and hypoexpression of human CYP2E1 gene in lung tumors
    709. Identification and characterization of a mitochondrial targeting signal in rat cytochrome P450 2E1 (CYP2E1)
    710. Identification and functional analysis of a novel human CYP2E1 far upstream enhancer
    711. Identification of 2-piperidone as a biomarker of CYP2E1 activity through metabolomic phenotyping
    712. Identification of a 16-nucleotide sequence that mediates post-transcriptional regulation of rat CYP2E1 by insulin
    713. Identification of a critical CYP2E1 epitope in patients with drug-induced liver injury from anesthetics (93.16)
    714. Identification of CYP2E1 in marmoset monkey
    715. Identification of CYP2E1-dependent genes involved in carbon tetrachloride-induced hepatotoxicity
    716. Identification of cytochrome CYP2E1 as critical mediator of alcohol effects on steatotic hepatocytes
    717. Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro
    718. Identification of deletions and duplications in the CYP2E1 gene in a population in Goiânia–GO by MLPA.
    719. Identification of inhibitory component in cinnamon—o-methoxycinnamaldehyde inhibits cyp1a2 and CYP2E1—
    720. Identification of Novel CYP2E1 Inhibitor to Investigate Cellular and Exosomal CYP2E1-Mediated Toxicity
    721. Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and CYP2E1-null …
    722. Identification of sequences responsible for intracellular targeting and membrane binding of rat CYP2E1 in yeast
    723. IL-4 promotes experimental drug-induced hepatitis by reducing immune responses to haptenated proteins and inhibiting regulatory responses to native CYP2E1 …
    724. IL-4-mediated transcriptional regulation of human CYP2E1 by two independent signaling pathways
    725. Immunohistochemical demonstration of the expression of CYP2E1 in human breast tumour and non-tumour tissues
    726. Immunohistochemical Detection of CYP2E1 and 2-S-Glutathionyl Acetate in Murine Lung Tumors: Diminished Formation of Reactive Intermediates of 1,1 …
    727. Immunohistochemical study of CYP2E1 in hepatocellular carcinoma carcinogenesis: examination with newly prepared anti-human CYP2E1 antibody
    728. Immunological detection of CYP2E1 in fresh rat lymphocytes and its pretranslational induction by fasting
    729. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients
    730. Impact of CYP2E1 polymorphisms on the risk of esophageal cancer
    731. Impact of CYP2E1, GSTA1 and GSTP1 gene variants on serum alpha glutathione S-transferase level in patients undergoing anaesthesia
    732. Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver
    733. Implication of xenobiotic metabolizing enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma
    734. in rats induced by aqueous extract of Polygoni Multiflori Radix, root of Polygonum multiflorum related to the activity inhibition of CYP1A2 or CYP2E1
    735. in urea in conjunction with L-arginine metabolism in the liver leads to induction of cytochrome P450 2E1 (CYP2E1): The role of urea in CYP2E1 induction by acute …
    736. In vitro evaluation of structural analogs of diallyl sulfide as novel CYP2E1 inhibitors for their protective effect against xenobiotic-induced toxicity and HIV …
    737. In vitro inhibition of human CYP2E1 and CYP3A by quercetin and myricetin in hepatic microsomes is not gender dependent
    738. In vitro metabolism of styrene to styrene oxide in liver and lung of CYP2E1 knockout mice
    739. In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African Green monkeys: induction by chronic nicotine treatment
    740. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians.
    741. In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene
    742. Inactivation of cytochrome P-450 (CYP2E1) and carboxylesterase (hydrolase A) enzymes by vinyl carbamate in murine pulmonary microsomes
    743. Inactivation of hepatic CYP2E1 by an epoxide of diallyl sulfone
    744. Inactivation of stress protein p8 increases murine carbon tetrachloride hepatotoxicity via preserved CYP2E1 activity
    745. Increase expression of CYP2E1 mRNA after methamphetamine administration in rats
    746. Increased bioaccumulation of urethane in CYP2E1-/-versus CYP2E1+/+ mice
    747. Increased Expression of CYP2E1 gene in gastric cancer may be a molecular marker for mazandaran province population
    748. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
    749. Increased prooxidant production and enhanced susceptibility to glutathione depletion in HepG2 cells co‐expressing HCV core protein and CYP2E1
    750. Increased toxicity by transforming growth factor-beta 1 in liver cells overexpressing CYP2E1
    751. Independent and combined effects of ethanol self-administration and nicotine treatment on hepatic CYP2E1 in African green monkeys
    752. Individual variability of CYP2E1 xenobiotic oxidation in human liver
    753. Induction and recovery time course of rat brain CYP2E1 after nicotine treatment
    754. Induction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration.
    755. Induction of brain CYP2E1 by chronic ethanol treatment and related oxidative stress in hippocampus, cerebellum, and brainstem
    756. Induction of brain CYP2E1 changes the effects of ethanol on dopamine release in nucleus accumbens shell
    757. Induction of catalase, alpha, and microsomal glutathione S‐transferase in CYP2E1 overexpressing HepG2 cells and protection against short‐term oxidative stress
    758. Induction of CYP1A1 and CYP2E1 in rat liver by histamine: binding and kinetic studies
    759. Induction of CYP2B and CYP2E1 in precision-cut rat liver slices cultured in defined medium
    760. Induction of CYP2E1 activity in Ctenopharyngodon idellus hepatocyte
    761. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6‐hydroxylation
    762. Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half …
    763. Induction of CYP2E1 in non-alcoholic fatty liver diseases
    764. Induction of CYP2E1 in testes of isoniazid-treated rats as possible cause of testicular disorders
    765. Induction of DNA strand breaks and oxidative stress in HeLa cells by ethanol is dependent on CYP2E1 expression
    766. Induction of hepatic CYP2E1 by a subtoxic dose of acetaminophen in rats: increase in dichloromethane metabolism and carboxyhemoglobin elevation
    767. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications
    768. Induction of rat hepatic CYP2E1 expression by arecoline in vivo
    769. Induction of SIRT1 by melatonin improves alcohol‐mediated oxidative liver injury by disrupting the CRBN‐YY1‐CYP2E1 signaling pathway
    770. Influence of Acarbose, Metformin and Pioglitazone on TNF-αand CYP2E1 in Liver Tissue of NAFLD Rat
    771. Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro
    772. INFLUENCE OF GENETIC ADMIXTURE ON POLYMORPHISMS OF ALCOHOL-METABOLIZING ENZYMES: ANALYSES OF MUTATIONS ON THE CYP2E1, ADH2, ADH3 AND …
    773. Influence of genetic admixture on polymorphisms of drug‐metabolizing enzymes: Analyses of mutations on NAT2 and CYP2E1 genes in a mixed Hispanic …
    774. Influence of GSTs, CYP2E1 and mEH polymorphisms on 1, 3-butadiene-induced micronucleus frequency in Chinese workers
    775. Influence of GSTT1, mEH, CYP2E1 and RAD51 polymorphisms on diepoxybutane-induced SCE frequency in cultured human lymphocytes
    776. Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans
    777. Influence of selected inhibitors on the metabolism of the styrene metabolite 4-vinylphenol in wild-type and CYP2E1 knockout mice
    778. Inhibition of autophagy promotes CYP2E1-dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and …
    779. Inhibition of chlorzoxazone metabolism, a clinical probe for